{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":15,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":15,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"5858a2241443","filters":{"venue":"Clinical Medicine Insights Therapeutics"}},"results":[{"id":"W1989502045","doi":"10.4137/cmt.s3783","title":"Lapatinib, a Dual-Targeted Small Molecule Inhibitor of EGFR and HER2, in HER2-Amplified Breast Cancer: From Bench to Bedside","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Lapatinib; Trastuzumab; Breast cancer; Cancer research; Medicine; Tyrosine kinase; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Metastatic breast cancer; Cancer; Targeted therapy; Pertuzumab; Letrozole; Oncology; Internal medicine; Receptor; Tamoxifen","authors":[{"name":"Roger Y. Tsang","is_ca":false},{"name":"Saeed Sadeghi","is_ca":false},{"name":"Richard S. Finn","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1881386438902378,"gpt":0.4205964844946525,"spread":0.2324578406044146,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005209575,0.0002636867,0.0003507814,0.0002813956,0.0001240751,0.0004870361,0.0002903806,0.0006442088,0.001050717],"category_scores_gemma":[0.0002777477,0.00008802707,0.0001713923,0.0002478746,0.0002070327,0.0006485138,0.0002727107,0.0008231355,0.000418749],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003409908,"about_ca_system_score_gemma":0.0002516528,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000143465,"about_ca_topic_score_gemma":0.0006338209,"domain_scores_codex":[0.9998848,0.00004046037,0.000009618837,0.00001247986,0.00003361975,0.00001888597],"domain_scores_gemma":[0.9999368,0.0000232259,0.00001025708,0.000001958627,0.00001049266,0.00001726779],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001055385,0.0006003969,0.001280529,0.001260327,0.00004207518,0.001834817,0.0001404662,0.0007552371,0.06811406,0.005163334,0.02129564,0.8984578],"study_design_scores_gemma":[0.002317633,0.01141565,0.01083467,0.0005829138,0.0003271528,0.03198189,0.0003027174,0.004540395,0.1261774,0.006713665,0.80471,0.00009573004],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.05774067,0.9065737,0.006178422,0.01139361,0.0009187723,0.00008223692,0.00007561404,0.0001647776,0.01687221],"genre_scores_gemma":[0.3252656,0.6409555,0.00881838,0.005087157,0.002385939,0.000102232,0.0002338696,0.00002729193,0.01712411],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001050717,"threshold_uncertainty_score":0.003515005,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069864063","doi":"10.4137/cmt.s11675","title":"Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)","year":2013,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Bedaquiline; Tuberculosis; Multiple drug resistance; Isoniazid; Antibiotics; Drug resistance; Internal medicine; Intensive care medicine; Clinical trial; Incidence (geometry); Mycobacterium tuberculosis; Microbiology; Pathology; Biology","authors":[{"name":"Stephen K. Field","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1024885167783378,"gpt":0.4154060033906332,"spread":0.3129174866122953,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001381653,0.0001742562,0.0006199784,0.0003285094,0.0001774244,0.0004543356,0.0005033024,0.0004111042,0.002410804],"category_scores_gemma":[0.001766373,0.00008283787,0.0004516412,0.0002824339,0.0003425525,0.0004345466,0.0003129934,0.0008784044,0.0004223684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003039904,"about_ca_system_score_gemma":0.0004158938,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004195257,"about_ca_topic_score_gemma":0.0007774741,"domain_scores_codex":[0.9994203,0.0002652174,0.0000759019,0.0000653102,0.0001454422,0.00002789454],"domain_scores_gemma":[0.9993349,0.0002464376,0.0002173916,0.00003024738,0.0001039805,0.00006705928],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.01326895,0.0008447981,0.006812012,0.004700062,0.0003656916,0.0005917984,0.0002103917,0.0004416584,0.02189488,0.001303882,0.003321124,0.9462447],"study_design_scores_gemma":[0.01757446,0.1544596,0.2060755,0.00527059,0.002977751,0.02411093,0.001205241,0.003444992,0.09453175,0.004069156,0.4860198,0.0002603207],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.249761,0.7258255,0.002879124,0.00366105,0.0005154405,0.0003030075,0.001191612,0.000136891,0.01572643],"genre_scores_gemma":[0.8362426,0.1556331,0.002621077,0.001735044,0.0003839354,0.0001285722,0.000829607,0.00002408516,0.002401998],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002410804,"threshold_uncertainty_score":0.008064926,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2759644066","doi":"10.1177/1179559x17731801","title":"Brexpiprazole in the Treatment of Major Depressive Disorder","year":2017,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network; St. Michael's Hospital","funders":"Ontario Brain Institute; Massachusetts General Hospital","keywords":"Partial agonist; Aripiprazole; PsycINFO; Major depressive disorder; Adjunctive treatment; Antipsychotic; Antidepressant; Medicine; Meta-analysis; Psychology; Atypical antipsychotic; Psychiatry; Psychotherapist; MEDLINE; Schizophrenia (object-oriented programming); Agonist; Internal medicine; Anxiety; Mood; Receptor","authors":[{"name":"Maryam I. Al Shirawi","is_ca":true},{"name":"Nicole E. Edgar","is_ca":true},{"name":"Sidney H. Kennedy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1311998809784387,"gpt":0.4398751764897023,"spread":0.3086752955112636,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009482481,0.0002395802,0.0008855078,0.001057756,0.0001155271,0.0004369313,0.0003395947,0.0005086501,0.001907743],"category_scores_gemma":[0.001964434,0.0001263546,0.0007288206,0.001044191,0.0001609232,0.0003192155,0.0002576102,0.0004099089,0.0002103571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003053542,"about_ca_system_score_gemma":0.0007319347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001152316,"about_ca_topic_score_gemma":0.004588435,"domain_scores_codex":[0.9993666,0.000262072,0.0001705575,0.00005292764,0.0001251111,0.00002272875],"domain_scores_gemma":[0.9992558,0.0003994336,0.0002291225,0.00001043779,0.000083604,0.0000216244],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002281329,0.00009858503,0.001045058,0.201578,0.002491292,0.0003343619,0.0001436349,0.0001623885,0.002405988,0.0004622172,0.005247341,0.7837498],"study_design_scores_gemma":[0.009394899,0.01140282,0.08228474,0.3882281,0.06831317,0.008072429,0.001200046,0.001433607,0.006828449,0.002539019,0.4201627,0.0001400183],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002555336,0.9966336,0.00004034982,0.0002306865,0.00004172331,0.00001687461,0.00004014485,0.000003471844,0.0004377799],"genre_scores_gemma":[0.02965352,0.969129,0.0003138935,0.0005047572,0.00008662899,0.000027591,0.00006740011,0.000001187115,0.0002160412],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001907743,"threshold_uncertainty_score":0.006381989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2761151032","doi":"10.1177/1179559x17734227","title":"Efficacy of Continuous Positive Airway Pressure Treatment in Patients with Cardiac Arrhythmia and Obstructive Sleep Apnea: What is the Evidence?","year":2017,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Toronto Rehabilitation Institute; Sunnybrook Health Science Centre; Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Continuous positive airway pressure; Obstructive sleep apnea; Cardiology; Cardiac arrhythmia; Internal medicine; Observational study; Heart failure; Positive airway pressure; Ejection fraction; Confounding; Coronary artery disease; Sleep apnea; Intensive care medicine; Atrial fibrillation","authors":[{"name":"Asmaa M. Abumuamar","is_ca":true},{"name":"Tatyana Mollayeva","is_ca":true},{"name":"Paul Sandor","is_ca":true},{"name":"David Newman","is_ca":true},{"name":"Kumaraswamy Nanthakumar","is_ca":true},{"name":"Colin M. Shapiro","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05185066215065454,"gpt":0.3690471978300446,"spread":0.3171965356793901,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01114942,0.0008353295,0.009077613,0.003727146,0.000565422,0.002894659,0.00272646,0.004309525,0.005051011],"category_scores_gemma":[0.05923015,0.0007827365,0.006668195,0.004724399,0.001173532,0.002926532,0.0008627184,0.001980866,0.0006163991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001772924,"about_ca_system_score_gemma":0.003387653,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002666324,"about_ca_topic_score_gemma":0.004802956,"domain_scores_codex":[0.9893034,0.003467266,0.004686965,0.0008182053,0.001520783,0.0002034674],"domain_scores_gemma":[0.917969,0.06475112,0.01145499,0.0009823383,0.004164523,0.0006780685],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002858668,0.0002624475,0.006309303,0.8117136,0.01874386,0.000144154,0.0001649238,0.00009915556,0.0002106632,0.0004808429,0.002814234,0.1561981],"study_design_scores_gemma":[0.002743235,0.002140549,0.0415983,0.8119749,0.1051836,0.0008280278,0.0006477052,0.0002505688,0.0004008035,0.0011467,0.03297383,0.0001118353],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001478339,0.9967507,0.00005300856,0.0008281367,0.0002162731,0.00006036264,0.0002025399,0.000003783449,0.0004068565],"genre_scores_gemma":[0.04263584,0.9518012,0.0006051314,0.002632973,0.001462829,0.0002576592,0.0004793315,0.000009395498,0.0001155905],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01114942,"threshold_uncertainty_score":0.05896449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965329525","doi":"10.4137/cmt.s4012","title":"Varenicline: Smoking Cessation in Patients with Medical and Psychiatric Comorbidity","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Provincial Laboratory of Public Health; University of Alberta","funders":"","keywords":"Varenicline; Smoking cessation; Medicine; Comorbidity; Psychiatry; Mental illness; Addiction; Nicotine replacement therapy; Pharmacotherapy; Nicotine; Tolerability; Mental health; Internal medicine; Adverse effect","authors":[{"name":"Serena Tonstad","is_ca":false},{"name":"Charl Els","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05322821542743384,"gpt":0.3753441157299476,"spread":0.3221159003025138,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002406739,0.0001883776,0.000487492,0.0001571453,0.0001891842,0.0002512196,0.0002337096,0.000667255,0.00396806],"category_scores_gemma":[0.0006142992,0.00008117491,0.0002152456,0.0002512735,0.0000764775,0.0002365146,0.0001948258,0.0006154358,0.0009044153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001320954,"about_ca_system_score_gemma":0.0002867641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003775202,"about_ca_topic_score_gemma":0.001722475,"domain_scores_codex":[0.9998987,0.00003524793,0.00001522974,0.00001562534,0.00001988815,0.00001527264],"domain_scores_gemma":[0.9998329,0.00002324276,0.00005277111,0.000005969895,0.00001290976,0.00007222702],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01521705,0.003125356,0.05505145,0.001696626,0.0003446145,0.002395624,0.0001390618,0.0002145099,0.02375569,0.0006827599,0.01292006,0.8844571],"study_design_scores_gemma":[0.0125553,0.04415679,0.7772655,0.001040956,0.001068912,0.03344823,0.0003530552,0.002817763,0.009532945,0.001415872,0.1162411,0.0001035509],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8755713,0.07781898,0.001997357,0.01087129,0.0006182262,0.0003631476,0.0007431056,0.0004809005,0.03153563],"genre_scores_gemma":[0.9728741,0.01711643,0.001910369,0.00289099,0.0004997561,0.00006299186,0.0005424385,0.0000117671,0.004091205],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00396806,"threshold_uncertainty_score":0.01327449,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981981010","doi":"10.4137/cmt.s5884","title":"Efficacy and Safety of Galantamine Hydrobromide in the Treatment of Mild to Moderate Dementia","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Galantamine; Dementia; Mood; Placebo; Medicine; Nausea; Psychiatry; Disease; Internal medicine; Donepezil; Alternative medicine","authors":[{"name":"Mark Oremus","is_ca":true},{"name":"Pasqualina Santaguida","is_ca":true},{"name":"Parminder Raina","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08946186334557535,"gpt":0.4202218599304458,"spread":0.3307599965848704,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02601546,0.001957359,0.012706,0.005218598,0.0005474104,0.002381564,0.001356375,0.002078377,0.001910201],"category_scores_gemma":[0.04199144,0.00135958,0.02416805,0.003134666,0.0007519872,0.001232914,0.001122499,0.00135275,0.0001785849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002209869,"about_ca_system_score_gemma":0.002956752,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002543237,"about_ca_topic_score_gemma":0.00666549,"domain_scores_codex":[0.9804802,0.01196824,0.004581983,0.0009453576,0.001707754,0.0003164207],"domain_scores_gemma":[0.978617,0.01580636,0.003714535,0.0005243234,0.001095328,0.0002424545],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0195082,0.0001700238,0.003519956,0.3438346,0.5903052,0.0002410204,0.0001496658,0.0007523326,0.0009775942,0.0002363629,0.0004799403,0.03982507],"study_design_scores_gemma":[0.01193757,0.004661501,0.005662115,0.02719045,0.9460307,0.0002822947,0.00007864273,0.0003725113,0.0006213312,0.000539643,0.002578772,0.00004440278],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.02145736,0.9747543,0.001052926,0.0004421372,0.0002982529,0.001213331,0.00027074,0.00002844528,0.0004823918],"genre_scores_gemma":[0.4589852,0.528814,0.006184065,0.001552172,0.0005684526,0.002934412,0.0004390094,0.00002532505,0.0004973404],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02601546,"threshold_uncertainty_score":0.1375846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029911300","doi":"10.4137/cmt.s2213","title":"Emerging Therapies for the Management of Multiple Sclerosis","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Apotex (Canada); Health Sciences Centre","funders":"","keywords":"Medicine; Multiple sclerosis; Data extraction; Clinical trial; MEDLINE; Cochrane Library; Randomized controlled trial; Placebo; Transplantation; Intensive care medicine; Internal medicine; Alternative medicine; Pathology; Immunology","authors":[{"name":"Michael Namaka","is_ca":true},{"name":"Christine Leong","is_ca":true},{"name":"Michael Prout","is_ca":true},{"name":"Josée-Anne Le Dorze","is_ca":true},{"name":"Mike Limerick","is_ca":true},{"name":"Emma E. Frost","is_ca":true},{"name":"Farid Esfahani","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2704279329610191,"gpt":0.4403211410679815,"spread":0.1698932081069624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006497475,0.001268291,0.002759127,0.00879401,0.0005114645,0.002392131,0.001455522,0.002058295,0.01274931],"category_scores_gemma":[0.01421594,0.0003232858,0.002103383,0.006008959,0.0006089572,0.002536515,0.001307871,0.001643121,0.001684386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001864069,"about_ca_system_score_gemma":0.004274245,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001267806,"about_ca_topic_score_gemma":0.003808387,"domain_scores_codex":[0.9939632,0.002271208,0.001821902,0.0003552415,0.001431924,0.0001565026],"domain_scores_gemma":[0.9906465,0.005302143,0.002639754,0.0001432779,0.001110721,0.0001576941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004650485,0.0001009954,0.0006614789,0.425782,0.001401394,0.0003495204,0.0002214626,0.0003073163,0.0007489232,0.003539755,0.01511211,0.5513101],"study_design_scores_gemma":[0.0006018769,0.0006893357,0.003898833,0.6962663,0.005238214,0.002212633,0.0004584011,0.0002809209,0.0007500802,0.003494083,0.28606,0.00004923363],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002717328,0.9965359,0.0003549947,0.0006769259,0.0002912139,0.0001919391,0.0001962023,0.00001326643,0.001467723],"genre_scores_gemma":[0.003271828,0.990925,0.002947176,0.001416231,0.0004407251,0.0003938652,0.0001657603,0.000006196559,0.0004333708],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01274931,"threshold_uncertainty_score":0.0426507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013609844","doi":"10.4137/cmt.s4500","title":"Gastric Acid-Related Diseases: Focus on Esomeprazole","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Esomeprazole; Omeprazole; Medicine; Rabeprazole; Gastroenterology; Proton-pump inhibitor; Clopidogrel; Internal medicine; Gastric acid; Famotidine; Helicobacter pylori; Aspirin; Stomach","authors":[{"name":"Bandar Al‐Judaibi","is_ca":false},{"name":"Nilesh Chande","is_ca":false},{"name":"George K. Dresser","is_ca":true},{"name":"N. Sultan","is_ca":true},{"name":"James C. Gregor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04990391487098689,"gpt":0.3820149494845545,"spread":0.3321110346135676,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005734414,0.0005800989,0.001176513,0.001421546,0.0002879828,0.001198902,0.0004170018,0.001815494,0.01112412],"category_scores_gemma":[0.0008526999,0.000175621,0.0004213479,0.001077142,0.0007237829,0.002194283,0.0008214254,0.001681886,0.003645164],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005363574,"about_ca_system_score_gemma":0.0005835206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009352205,"about_ca_topic_score_gemma":0.002735266,"domain_scores_codex":[0.9997371,0.00006869721,0.00002739282,0.00004747484,0.00008109453,0.00003828067],"domain_scores_gemma":[0.9990101,0.0004448319,0.00005917809,0.00003762134,0.0002972806,0.0001509872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003712706,0.0003022782,0.004571875,0.005778138,0.0001604619,0.005609381,0.0002412545,0.0002308207,0.004246367,0.008753895,0.1262678,0.8434664],"study_design_scores_gemma":[0.0000792647,0.0004122158,0.01661367,0.003297945,0.0002126528,0.03045938,0.0003264033,0.000368089,0.0007626088,0.0049397,0.9424883,0.00003965063],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002808353,0.9473093,0.0006478222,0.01684859,0.003997317,0.0000167029,0.00004060408,0.00003367108,0.0282976],"genre_scores_gemma":[0.01951265,0.9252433,0.000903292,0.009475256,0.03224261,0.00001668648,0.0000634868,0.00002496936,0.01251777],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01112412,"threshold_uncertainty_score":0.03721386,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2084281139","doi":"10.4137/cmt.s4456","title":"Pegylated Liposomal Doxorubicin in the Management of Ovarian Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Carboplatin; Ovarian cancer; Doxorubicin; Paclitaxel; Drug; Oncology; Pharmacology; Internal medicine; Cancer; Chemotherapy; Cisplatin","authors":[{"name":"Gabriella Ferrandina","is_ca":false},{"name":"Marco Petrillo","is_ca":false},{"name":"Angelo Licameli","is_ca":false},{"name":"Gilda Fuoco","is_ca":false},{"name":"Giovanni Scambia","is_ca":false},{"name":"Giacomo Corrado","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08930760328561985,"gpt":0.4170289362062235,"spread":0.3277213329206037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003597073,0.0001550125,0.0002161661,0.0003959125,0.00006498917,0.0002077371,0.0001543367,0.0003286222,0.0007050961],"category_scores_gemma":[0.0003152977,0.00005902116,0.0000840377,0.0002790685,0.0001875524,0.0002909115,0.0002183915,0.00049716,0.0003202894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003102979,"about_ca_system_score_gemma":0.0002229958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002883741,"about_ca_topic_score_gemma":0.0004644124,"domain_scores_codex":[0.9999344,0.0000219545,0.000008664167,0.000009554382,0.00001954548,0.000005787493],"domain_scores_gemma":[0.9999378,0.00002376147,0.00001664306,0.000003031067,0.000007725161,0.0000110385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0006767976,0.0001032188,0.0006903464,0.001549167,0.00003761301,0.0008526592,0.00008691444,0.0007680108,0.01327769,0.002931082,0.006135737,0.9728908],"study_design_scores_gemma":[0.0006771212,0.003750948,0.01119147,0.001492815,0.0001557037,0.01363248,0.0001199769,0.002133228,0.02243801,0.004852636,0.9395069,0.00004876105],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01926701,0.9696632,0.002336837,0.002552723,0.0004580126,0.00003783064,0.00003329169,0.0000280206,0.005623122],"genre_scores_gemma":[0.1614323,0.8279808,0.003289173,0.001237445,0.0009351908,0.00005283504,0.0001081708,0.00001386504,0.004950223],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0007050961,"threshold_uncertainty_score":0.002358794,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2275755947","doi":"10.4137/cmt.s18886","title":"Stroke Prevention with Percutaneous Left Atrial Appendage Closure","year":2016,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Atrial fibrillation; Left atrial appendage occlusion; Percutaneous; Stroke (engine); Cardiology; Internal medicine; Thrombus; Occlusion; Thromboembolic stroke; Atrial Appendage; Thrombosis; Warfarin","authors":[{"name":"Peter Fahmy","is_ca":true},{"name":"Jacqueline Saw","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1523130816376864,"gpt":0.4183604860180196,"spread":0.2660474043803333,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004470824,0.0002624064,0.0007394261,0.0007989099,0.0003130641,0.0007495304,0.0002430117,0.0004156055,0.005276982],"category_scores_gemma":[0.002252642,0.00007351566,0.0008678871,0.0004425244,0.0002424745,0.0005076525,0.0004347152,0.0009557228,0.00084824],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002437174,"about_ca_system_score_gemma":0.0005509447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000333445,"about_ca_topic_score_gemma":0.0004628742,"domain_scores_codex":[0.9995093,0.0001315041,0.00007806584,0.00006669974,0.0001664131,0.00004796576],"domain_scores_gemma":[0.9995322,0.0001492125,0.0001685108,0.00002325483,0.00006558417,0.00006128481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007729417,0.0007839485,0.007644567,0.002953961,0.0004325635,0.001383411,0.0001102922,0.0002905891,0.002190508,0.002826362,0.01195587,0.9686549],"study_design_scores_gemma":[0.005202155,0.02135883,0.2386781,0.02039977,0.003766431,0.06818704,0.0007876526,0.002851424,0.01527807,0.04244938,0.580856,0.0001852031],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.07445379,0.7995583,0.01632563,0.01599343,0.002821059,0.0003865668,0.0004535101,0.0004828363,0.08952475],"genre_scores_gemma":[0.6109012,0.3498541,0.0134105,0.005044387,0.009754326,0.0003802209,0.0007607113,0.00007757693,0.009817048],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005276982,"threshold_uncertainty_score":0.01765323,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007434442","doi":"10.4137/cmt.s4670","title":"Effectiveness and Safety of Rizatriptan Benzoate 10 mg in the Treatment of Migraine Headaches","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; GDI Integrated Facility Services (Canada); Merck Canada Inc. (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Rizatriptan; Medicine; Migraine; Nausea; Headaches; Somnolence; Adverse effect; Anesthesia; Triptans; Prospective cohort study; Internal medicine; Sumatriptan; Surgery","authors":[{"name":"Michel Aubé","is_ca":true},{"name":"Fridon Chouha","is_ca":true},{"name":"Julie Vaillancourt","is_ca":true},{"name":"John S. Sampalis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09138714600609213,"gpt":0.407207713880599,"spread":0.3158205678745069,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007622626,0.0002340285,0.0005901896,0.000206306,0.0001152959,0.0003039125,0.0002435566,0.0003038873,0.0009199967],"category_scores_gemma":[0.001017291,0.000128282,0.0004673693,0.0001517698,0.0002317719,0.0002015752,0.0001277728,0.000428463,0.000222333],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002205952,"about_ca_system_score_gemma":0.000293337,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004280627,"about_ca_topic_score_gemma":0.0008851624,"domain_scores_codex":[0.9995651,0.0001810959,0.00004427876,0.00005469255,0.0001076285,0.00004722398],"domain_scores_gemma":[0.9994647,0.0001577455,0.0002553607,0.00002567481,0.00002259023,0.00007387793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2887109,0.01519678,0.09766307,0.001141248,0.001840971,0.0005823797,0.0002587103,0.001898647,0.12146,0.0001192182,0.001120907,0.4700071],"study_design_scores_gemma":[0.04779227,0.4846096,0.4483663,0.00009353751,0.001195533,0.001467732,0.00009389412,0.001410807,0.01188387,0.00009436072,0.002946778,0.00004536864],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996181,0.003026217,0.00008348061,0.00005813465,0.00001373532,0.00007005212,0.0001469007,0.00001201821,0.000408363],"genre_scores_gemma":[0.9977692,0.001413043,0.000189559,0.00007681223,0.00004642328,0.00005006983,0.0002454344,0.00000247344,0.0002069282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009199967,"threshold_uncertainty_score":0.004031301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005153650","doi":"10.4137/cmt.s3567","title":"Risperidone for Individuals with Refractory Schizophrenia","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Risperidone; Schizophrenia (object-oriented programming); Refractory (planetary science); Antipsychotic; Clozapine; Psychiatry; Atypical antipsychotic; Medicine; Psychology","authors":[{"name":"Priya Subramanian","is_ca":true},{"name":"Abraham Rudnick","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08233823778095527,"gpt":0.4070628769732801,"spread":0.3247246391923249,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009694924,0.0002341302,0.0006342276,0.001252911,0.0001756868,0.0003406032,0.0002130723,0.0005841024,0.002075602],"category_scores_gemma":[0.003548347,0.0001038121,0.0007017021,0.000779036,0.0002079795,0.0002878118,0.0002470799,0.0003166663,0.0004011405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004757631,"about_ca_system_score_gemma":0.001491898,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001393086,"about_ca_topic_score_gemma":0.005854407,"domain_scores_codex":[0.9993801,0.0003229528,0.0001463671,0.00002733709,0.00009802436,0.00002505254],"domain_scores_gemma":[0.9983607,0.000906351,0.0005419144,0.00002220995,0.00009755971,0.00007126739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002244661,0.0001220766,0.005888695,0.09842727,0.001171563,0.003930103,0.0005977696,0.000158106,0.002305601,0.001027149,0.02662779,0.8574991],"study_design_scores_gemma":[0.006076949,0.006401971,0.1224894,0.1206264,0.01035413,0.03599637,0.001946816,0.0004913204,0.004293567,0.005859045,0.685328,0.0001359261],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01372442,0.9767616,0.0001591041,0.002540978,0.0002720984,0.00008395041,0.0001745344,0.00001947815,0.006263802],"genre_scores_gemma":[0.2162574,0.7752141,0.001522023,0.003807914,0.0007892856,0.0001768883,0.0002853597,0.000006839487,0.001940196],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002075602,"threshold_uncertainty_score":0.006943643,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015849975","doi":"10.4137/cmt.s7586","title":"Early Mitoxantrone-Induced Cardiotoxicity Detected in Secondary Progressive Multiple Sclerosis","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Mitoxantrone; Medicine; Cardiotoxicity; Multiple sclerosis; Tolerability; Internal medicine; Oncology; Ejection fraction; Natalizumab; Disease; Adverse effect; Chemotherapy; Heart failure; Immunology","authors":[{"name":"Michael Namaka","is_ca":true},{"name":"Dana Turcotte","is_ca":true},{"name":"Meghann Klowak","is_ca":true},{"name":"Christine Leong","is_ca":true},{"name":"Amy Grossberndt","is_ca":true},{"name":"J-A. Le Dorze","is_ca":true},{"name":"Michael Prout","is_ca":true},{"name":"S Andresen","is_ca":true},{"name":"Lam Vuong","is_ca":true},{"name":"Maria Melanson","is_ca":true},{"name":"Emma E. Frost","is_ca":true},{"name":"Malcolm Doupe","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3327976076464534,"gpt":0.3996232613354747,"spread":0.06682565368902127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001103273,0.0002662838,0.0004922666,0.0003562435,0.0001943358,0.0001570822,0.0001628423,0.0002951673,0.001736885],"category_scores_gemma":[0.001135495,0.00010306,0.0002333645,0.0002165661,0.0002651208,0.0001688268,0.0001685402,0.0004282093,0.0001654376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001771342,"about_ca_system_score_gemma":0.000144096,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002636417,"about_ca_topic_score_gemma":0.0003504511,"domain_scores_codex":[0.999658,0.0001724852,0.00003474338,0.00004054149,0.00005943384,0.0000346781],"domain_scores_gemma":[0.9993035,0.0002228003,0.0002154976,0.00005786359,0.00007678031,0.0001234749],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08996353,0.006582481,0.5051774,0.0009950203,0.0004117954,0.01161648,0.0006108074,0.000513531,0.3181678,0.0001668336,0.0004591334,0.06533518],"study_design_scores_gemma":[0.001613408,0.1095193,0.8343149,0.00002971705,0.0002982655,0.01310437,0.0001375802,0.0006165219,0.03937868,0.00007457817,0.0008992949,0.00001334126],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988416,0.0004625031,0.0001547405,0.000010016,0.000003536697,0.00008219458,0.00003438036,0.000005598108,0.0004054318],"genre_scores_gemma":[0.9996485,0.00007511507,0.0001010548,0.00001110869,0.000005523696,0.00001902317,0.00003881164,6.796242e-7,0.0001002329],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001736885,"threshold_uncertainty_score":0.005834699,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W96046762","doi":"10.4137/cmt.s9566","title":"Review of Treatment Options for Myelofibrosis: Focus on Ruxolitinib","year":2013,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Ruxolitinib; Myelofibrosis; Polycythaemia; Medicine; Food and drug administration; Clinical trial; Janus kinase; Janus kinase 2; Internal medicine; Pharmacology; Bone marrow","authors":[{"name":"Donal P. McLornan","is_ca":false},{"name":"John A. Laurie","is_ca":false},{"name":"Claire Harrison","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1597702826813349,"gpt":0.4327420877786614,"spread":0.2729718050973265,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005553084,0.0006204105,0.001478969,0.001852706,0.0002265508,0.0006501771,0.0007527067,0.0007109119,0.004220445],"category_scores_gemma":[0.0007776808,0.0001885663,0.0005847165,0.001699202,0.0003020122,0.001101478,0.0003492641,0.001506056,0.001675444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004459522,"about_ca_system_score_gemma":0.0005053347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004808788,"about_ca_topic_score_gemma":0.001492756,"domain_scores_codex":[0.9997713,0.00006483554,0.00004061187,0.000036958,0.00007075119,0.00001546841],"domain_scores_gemma":[0.9995126,0.0002918067,0.00007540212,0.00001081217,0.00007077667,0.00003858001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001319121,0.0000911044,0.0002097506,0.009058848,0.0001238338,0.0006728822,0.00004341768,0.000363646,0.001455709,0.00160895,0.04026796,0.945972],"study_design_scores_gemma":[0.00007476415,0.0002472525,0.001684853,0.006864716,0.0002114415,0.006400004,0.00005814292,0.0001872223,0.0004968759,0.001251159,0.9825014,0.00002218189],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002691169,0.9969422,0.0001632834,0.0006563353,0.0002516032,0.000005508664,0.00001463362,0.000007223642,0.001690169],"genre_scores_gemma":[0.001664664,0.9956259,0.0003975911,0.0006901472,0.000662843,0.000009318798,0.00003866614,0.000003316411,0.0009074422],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004220445,"threshold_uncertainty_score":0.01411885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2049767450","doi":"10.4137/cmt.s4120","title":"Intranasal Ciclesonide in Allergic Rhinitis","year":2010,"lang":"en","type":"article","venue":"Clinical Medicine Insights Therapeutics","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Ciclesonide; Medicine; Nasal administration; Nasal spray; Asthma; Dermatology; Immunology; Inhaled corticosteroids","authors":[{"name":"Harissios Vliagoftis","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07250437245537755,"gpt":0.3739266189113618,"spread":0.3014222464559842,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003546119,0.0002559462,0.0005893414,0.0003894457,0.0001653667,0.0003101131,0.0002101837,0.0005460388,0.002516976],"category_scores_gemma":[0.0003623079,0.00006879921,0.000213982,0.0003508884,0.0001832114,0.0002704619,0.000211397,0.0006906221,0.001138033],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002049275,"about_ca_system_score_gemma":0.0003293263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005930493,"about_ca_topic_score_gemma":0.001585284,"domain_scores_codex":[0.9998129,0.00006003784,0.00002346268,0.00002085654,0.00006601411,0.00001675998],"domain_scores_gemma":[0.9998732,0.0000421178,0.00003375265,0.000007222141,0.00002831118,0.00001536989],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0006048238,0.0002706619,0.0009673933,0.004261124,0.00008121166,0.002215204,0.00008961364,0.00008865903,0.01731894,0.0008969432,0.009589083,0.9636164],"study_design_scores_gemma":[0.0007265137,0.006794957,0.03708364,0.003421342,0.0008248927,0.05050084,0.0003384404,0.0003895547,0.02193928,0.002544515,0.8753786,0.00005747533],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01145775,0.9794202,0.000505351,0.0009894854,0.0004692037,0.00002447908,0.00002097594,0.00002480924,0.007087653],"genre_scores_gemma":[0.1351499,0.8502274,0.001460911,0.001388404,0.001298035,0.00004504748,0.0000728718,0.000009125482,0.01034833],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.002516976,"threshold_uncertainty_score":0.008420169,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}